Atlas Trials

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM

Clinical trial NCT05767346 · COMPLETED

Trial details

NCT number
NCT05767346
Sponsor
Cytokinetics
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Start date
2023-06-20
Primary completion
2025-02-28
Enrollment
175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.